Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life

Pharmacotherapy

Volumn 22, Issue 6, 2002, Pages 759-765

  Zillich, Alan J ^a   Ryan, Melody ^b   Adams, Aimee ^b   Yeager, Bryan ^b   Farris, Karen ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE GUM; NICOTINE; NICOTINIC AGENT;

ADULT; ARTICLE; BEHAVIOR MODIFICATION; CLINICAL ARTICLE; CLINICAL PHARMACY; FEMALE; HUMAN; MALE; MENTAL HEALTH; NICOTINE REPLACEMENT THERAPY; PATIENT COUNSELING; QUALITY OF LIFE; QUESTIONNAIRE; SELF CONTROL; SMOKING CESSATION; CLINICAL TRIAL; METHODOLOGY; PHARMACIST; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; TOPICAL DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ADMINISTRATION, TOPICAL; ADULT; FEMALE; HUMAN; MALE; NICOTINE; NICOTINIC AGONISTS; PHARMACISTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0036014886     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.9.759.34073     Document Type: Article

References (39)

1. Cigarette smoking-attributable mortality and years of potential life lost - United States, 1990
2. Smoking cessation during previous year among adults - United States, 1990 and 1991
3. A comparison of psychological and pharmacological treatment in smoking cessation
4. A controlled trial of nicotine chewing gum in a smoking withdrawal clinic
5. Randomised controlled trial of nicotine chewing-gum
6. Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking
7. Effect of nicotine chewing gum in smoking cessation. A randomized, placebo-controlled, double-blind study
8. Degree of addiction and effectiveness of nicotine gum therapy for smoking
9. Combination of behavioral smoking cessation with transdermal nicotine substitution
10. Controlled trial of transdermal nicotine patch in tobacco withdrawal
11. Effectiveness of a transdermal nicotine system in smoking cessation studies
12. A doubleblind trial of a 16-hour transdermal nicotine patch in smoking cessation
13. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling
14. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice
15. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement
16. US public health service clinical practice guideline: Treating tobacco use and dependence
17. Practice guideline for the treatment of patients with nicotine dependence
18. Effect of general practitioners' advice against smoking
19. The impact of routine advice on smoking cessation from family physicians
20. Controlled trial of three different antismoking interventions in general practice
21. Stop-smoking program using nicotine reduction therapy and behavior modification for heavy smokers
22. Nicotine reduction therapy and relapse prevention for heavy smokers: 3-Year follow-up
23. Results of a smoking cessation clinic in community pharmacy practice
24. Use of bupropion SR in a pharmacistmanaged outpatient smoking-cessation program
25. A randomized controlled trial of a smoking cessation intervention based in community pharmacies
26. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: A randomised controlled trial in Scotland
27. Stages and processes of self-change of smoking: Toward an integrative model of change
28. The integration of health quality of life in clinical research: Experiences from cardiovascular clinical trials
29. A comparison of smokers' and ex-smokers' health-related quality of life
30. The health-related quality-of-life of never smokers, ex-smokers, and light, moderate, and heavy smokers
31. Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program
32. A double blind study of 2 mg versus 4 mg nicotine-gum in an industrial setting
33. Development of the smoking cessation quality of life questionnaire
34. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment
35. Measuring nicotine dependence: A review of the Fagerstrom tolerance questionnaire
36. Development and implementation of a smoking cessation clinic in community pharmacy practice
37. Pharmacists' role in a smoking-cessation program at a managed health care organization
38. Pharmacists' role in a smoking-cessation program at a health maintenance organization